The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
locations
of all universities in the world*
in Israel and Europe for research on artificial intelligence
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Prof. Segal leads a multidisciplinary research laboratory focused on developing advanced nanomaterials-based technologies for medical diagnostics. Her group designs sensitive biosensing platforms that can detect biological markers of disease with the goal of enabling earlier, faster, and more accessible diagnosis. The lab also applies its expertise in nanomaterials and biotechnology to therapeutic delivery, food safety, and sustainable agriculture.
She has published widely in leading scientific journals and has received prestigious international recognition, including from the American Chemical Society. She also contributes to the broader scientific community through service on advisory boards of leading journals and by leading collaborative research initiatives that connect academia, industry, and international partners.
Through her research and leadership, Prof. Segal is helping advance technologies that could change how diseases are detected, monitored, and treated — while training the next generation of scientists and engineers to translate discoveries into meaningful impact.
Trained as a chemical engineer, she earned her Ph.D. at the Technion and completed postdoctoral research as a Rothschild Fellow at the University of California, San Diego.
Diagnosing urinary tract infections is easy. Most people know themselves when they have one. But identifying the type of antibiotic needed to cure that infection requires a seven-hour test. It could be a day or two before the correct drug is prescribed. Usually, patients are started on a general antibiotic. But if it’s the wrong one, it must be changed. And that contributes to the problem of antibiotic resistance. Now, thanks to a team of Technion faculty, students, and alumni, led by Professor Ester Segal of the Technion Faculty of Biotechnology and Food Engineering, a clinical assay capable of detecting…
Technion’s Ingenious Approach to Sustainable Food Tech Featuring Professors Marcelle Machluf, Ester Segal,and Uri Lesmes The world’s food system is reaching a crisis point: waste, overfishing, deforestation, greenhouse gas emissions from farming, and more are destroying the planet. As the global population keeps growing, food security is fast becoming one of the major challenges facing […]
A Breakthrough From the Technion Together with collaborators from leading medical centers in Israel, the United States, Europe, and Australia, Shamai and his team at the Technion have developed an AI model that predicts both the risk that breast cancer will return and whether a patient is likely to benefit from chemotherapy — offering a […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.